ARS Pharmaceuticals(SPRY)
$3.89+0.08 (+2.10%)
SPRY
ARS Pharmaceuticals earnings date
$3.89
At close:+0.08 (+2.10%)
Want to see SPRY full AI Analyst Report?
ARS Pharmaceuticals (SPRY) Q2 2023 Earnings Report
593 Followers
SPRY Q2 2023 EPS Results
- Actual EPS
- -$0.18
- Consensus EPS
- -$0.17
- Beat/Miss
- Missed by -$0.01
- One Year Ago EPS
- -$0.55
SPRY Q2 2023 Revenue Results
- Actual Revenue
- $10.00K
- Expected Revenue
- $0
- Beat/Miss
- Beat by +$10.00K
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/10/2023
- Time
- After Close
- Conference Call
- Thursday, August 10, 2023
SPRY Upcoming Earnings
ARS Pharmaceuticals's next earnings date is estimated for March 25, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
SPRY Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 25, 2027 | 2026 (Q4) | -0.28- | -0.41 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.30-0.36 | -0.52 | 30.77% (+0.16) | |
| Aug 13, 2026 | 2026 (Q2) | -0.48-0.63 | -0.46 | -36.96% (-0.17) | |
| May 15, 2026 | 2026 (Q1) | -0.52-0.61 | -0.35 | -74.29% (-0.26) | |
| Mar 09, 2026 | 2025 (Q4) | -0.43-0.41 | 0.48 | -185.42% (-0.89) | |
| Nov 10, 2025 | 2025 (Q3) | -0.45-0.52 | -0.2 | -160.00% (-0.32) | |
| Aug 13, 2025 | 2025 (Q2) | -0.46-0.46 | -0.13 | -253.85% (-0.33) | |
| May 14, 2025 | 2025 (Q1) | -0.34-0.35 | -0.11 | -218.18% (-0.24) | |
| Mar 20, 2025 | 2024 (Q4) | -0.240.48 | -0.07 | 785.71% (+0.55) | |
| Nov 13, 2024 | 2024 (Q3) | -0.14-0.20 | -0.16 | -25.00% (-0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

